Hims & Hers Health (HIMS) director Cosgrove receives grant of 8,223 RSUs

Q: What did Delos M. Cosgrove report in this Form 4 for HIMS?

Delos M. Cosgrove reported an award of 8,223 Restricted Stock Units (RSUs) linked to Hims & Hers Health, Inc. Class A Common Stock. These RSUs were granted at $0.00 per unit as a form of equity compensation, not an open-market purchase.

Q: What are the vesting terms of Cosgrove’s 8,223 HIMS RSUs?

The 8,223 RSUs vest in full on the first company quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date , provided Cosgrove maintains continuous service through that vesting date.

Q: What does each HIMS RSU granted to Cosgrove represent?

Each RSU granted to Cosgrove represents a contingent right to receive one share of Hims & Hers Health, Inc. Class A Common Stock. The right becomes actual shares only upon satisfying the continuous service and vesting conditions defined in the award’s terms.

Q: Was Cosgrove’s HIMS RSU transaction a market purchase or sale?

No, this transaction was a grant/award acquisition of 8,223 RSUs at $0.00 per unit , not a market purchase or sale. It reflects equity compensation rather than a discretionary trade in the open market for Hims & Hers Health, Inc. stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Cosgrove Delos M. reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. director Delos M. Cosgrove reported an award of 8,223 Restricted Stock Units (RSUs) relating to Class A Common Stock. The RSUs were granted at $0.00 per unit, bringing his reported direct holdings from this award to 8,223 RSUs.

Each RSU represents a contingent right to receive one share of Class A Common Stock. Subject to continuous service, the RSUs will vest in full on the first quarterly vesting date after the earlier of the company’s next annual stockholder meeting or the first anniversary of the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cosgrove Delos M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit ^F1	8,223	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 8,223 shares (Direct)

Footnotes (1)

F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

Key Figures

RSUs granted: 8,223 RSUs Grant price per RSU: $0.00 per unit Holdings after transaction: 8,223 RSUs

3 metrics

RSUs granted 8,223 RSUs Restricted Stock Units awarded to director Delos M. Cosgrove

Grant price per RSU $0.00 per unit Reported transaction price for the RSU award

Holdings after transaction 8,223 RSUs Total direct RSUs reported following the award

Key Terms

Restricted Stock Units, contingent right, continuous service, vesting date

4 terms

Restricted Stock Units financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"RSUs which represent a contingent right to receive one share of Class A Common Stock"

continuous service financial

"Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date"

vesting date financial

"will vest in full on the first Company quarterly vesting date to occur after the earlier of"

FAQ

What did Delos M. Cosgrove report in this Form 4 for HIMS?

Delos M. Cosgrove reported an award of 8,223 Restricted Stock Units (RSUs) linked to Hims & Hers Health, Inc. Class A Common Stock. These RSUs were granted at $0.00 per unit as a form of equity compensation, not an open-market purchase.

How many HIMS Restricted Stock Units did Cosgrove hold after this transaction?

After the reported award, Cosgrove’s direct holdings from this grant total 8,223 RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the vesting conditions described in the filing’s footnote.

What are the vesting terms of Cosgrove’s 8,223 HIMS RSUs?

The 8,223 RSUs vest in full on the first company quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date, provided Cosgrove maintains continuous service through that vesting date.

What does each HIMS RSU granted to Cosgrove represent?

Each RSU granted to Cosgrove represents a contingent right to receive one share of Hims & Hers Health, Inc. Class A Common Stock. The right becomes actual shares only upon satisfying the continuous service and vesting conditions defined in the award’s terms.

Was Cosgrove’s HIMS RSU transaction a market purchase or sale?

No, this transaction was a grant/award acquisition of 8,223 RSUs at $0.00 per unit, not a market purchase or sale. It reflects equity compensation rather than a discretionary trade in the open market for Hims & Hers Health, Inc. stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 04:22 PM Accepted by SEC EDGAR 08/14/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cosgrove Delos M.

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO,

CALIFORNIA

94123

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	08/12/2026		A		8,223		⁽¹⁾	⁽¹⁾	Class A Common Stock	8,223	$0	8,223	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Delos M Cosgrove	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR